Chunjiong F. Wang

Tianjin, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 27 publications

Author Correction: Dual-targeted siRubicon delivery strategy triggers hepatocellular lipophagy for mitigating liver steatosis.

Author Correction: Dual-targeted siRubicon delivery strategy triggers hepatocellular lipophagy for mitigating liver steatosis.

Journal: Nature communications

Published: February 05, 2026

Sexually Dimorphic Impacts of Early Life BCAAs Supplementation on Metabolic Dysfunctions in Adult Mice.

Sexually Dimorphic Impacts of Early Life BCAAs Supplementation on Metabolic Dysfunctions in Adult Mice.

Journal: Diabetes, obesity & metabolism

Published: January 12, 2026

Downregulation of PCYT2 by increased portal pressure safeguards liver regeneration after partial hepatectomy.

Downregulation of PCYT2 by increased portal pressure safeguards liver regeneration after partial hepatectomy.

Journal: Theranostics

Published: June 03, 2025

Dual-targeted siRubicon delivery strategy triggers hepatocellular lipophagy for mitigating liver steatosis.

Dual-targeted siRubicon delivery strategy triggers hepatocellular lipophagy for mitigating liver steatosis.

Journal: Nature communications

Published: July 22, 2024

Revealing the crosstalk between LOX+ fibroblast and M2 macrophage in gastric cancer by single-cell sequencing.

Revealing the crosstalk between LOX+ fibroblast and M2 macrophage in gastric cancer by single-cell sequencing.

Journal: BMC cancer

Published: June 26, 2024

Increased CHCHD2 expression promotes liver fibrosis in nonalcoholic steatohepatitis via Notch/osteopontin signaling.

Increased CHCHD2 expression promotes liver fibrosis in nonalcoholic steatohepatitis via Notch/osteopontin signaling.

Journal: JCI insight

Published: June 06, 2022

Phosphorylation of 17β-hydroxysteroid dehydrogenase 13 at serine 33 attenuates nonalcoholic fatty liver disease in mice.

Phosphorylation of 17β-hydroxysteroid dehydrogenase 13 at serine 33 attenuates nonalcoholic fatty liver disease in mice.

Journal: Nature communications

Published: January 20, 2022

The Annexin A2-Notch regulatory loop in hepatocytes promotes liver fibrosis in NAFLD by increasing osteopontin expression.

The Annexin A2-Notch regulatory loop in hepatocytes promotes liver fibrosis in NAFLD by increasing osteopontin expression.

Journal: Biochimica et biophysica acta. Molecular basis of disease

Published: January 13, 2022

Editorial: The Role of Bioactive Lipids in Homeostasis and Pathology.

Editorial: The Role of Bioactive Lipids in Homeostasis and Pathology.

Journal: Frontiers in physiology

Published: September 10, 2021

Effect of ω-3 Polyunsaturated Fatty Acids-Derived Bioactive Lipids on Metabolic Disorders.

Effect of ω-3 Polyunsaturated Fatty Acids-Derived Bioactive Lipids on Metabolic Disorders.

Journal: Frontiers in physiology

Published: December 27, 2020

Coupling of Integrin α5 to Annexin A2 by Flow Drives Endothelial Activation.

Coupling of Integrin α5 to Annexin A2 by Flow Drives Endothelial Activation.

Journal: Circulation research

Published: July 17, 2020

Inhibition of soluble epoxide hydrolase ameliorates hyperhomocysteinemia-induced hepatic steatosis by enhancing β-oxidation of fatty acid in mice.

Inhibition of soluble epoxide hydrolase ameliorates hyperhomocysteinemia-induced hepatic steatosis by enhancing β-oxidation of fatty acid in mice.

Journal: American journal of physiology. Gastrointestinal and liver physiology

Published: February 22, 2019

Showing 1-12 of 27

Last Updated: 09/26/2026